ClinConnect ClinConnect Logo
Search / Trial NCT05439291

Comparing Operative vs Non Operative Treatment for Pilonidal Disease

Launched by STANFORD UNIVERSITY · Jun 27, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Pilonidal Surgery Pilonidal Excision Pilonidal Recurrence

ClinConnect Summary

This clinical trial is looking at two different ways to treat pilonidal disease, a condition that can cause painful cysts or abscesses near the tailbone. Researchers want to find out if surgery is necessary after a patient’s initial symptoms go away, especially if they follow a regular hair removal routine, like getting laser hair removal. The trial is currently recruiting participants who have pilonidal disease and are at least 8 years old, as long as they can read and understand English or Spanish.

If you or someone you know is eligible and decides to participate, you can expect to be closely monitored throughout the study to see how well both treatment options work. This research may help doctors understand whether surgery is really needed for certain patients or if managing hair removal can be enough to keep symptoms from coming back. Your involvement could contribute valuable information to improve care for others with this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients at Stanford Healthcare with pilonidal disease.
  • Patients over the age of 8yrs.
  • Exclusion Criteria:
  • Inability to read, write or understand English \*\*\*or Spanish
  • Intellectual disability precluding the patient from being able to comprehend or respond to the questionnaire

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Palo Alto, California, United States

Patients applied

0 patients applied

Trial Officials

Bill Chiu, MD

Principal Investigator

Stanford University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials